$0.130
+0.0035 (+2.79%)
At Close: Aug 04, 2026
KELOWNA, BC / ACCESS Newswire / July 22, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the successful completion of a comprehensive facil
LAS VEGAS, July 21, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-re
Avant Brands Reports Q2 2026 Results Highlighted by 34% Growth in Recreational Revenue
08:30am, Wednesday, 15'th Jul 2026
KELOWNA, BC / ACCESS Newswire / July 15, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, to
Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy
08:45am, Wednesday, 20'th May 2026
LAS VEGAS, May 20, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-rel
Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders
05:55pm, Monday, 04'th May 2026
KELOWNA, BC / ACCESS Newswire / May 4, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the voting results from its annual general and speci
Avant Brands Announces its Annual General and Special Meeting
04:30pm, Wednesday, 15'th Apr 2026
KELOWNA, BC / ACCESS Newswire / April 15, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce its upcoming annual general and special meeting (
Avant Brands Reports Q1 2026 Results Highlighted by 37% Growth in Recreational Revenue
04:30pm, Tuesday, 14'th Apr 2026
KELOWNA, BC / ACCESS Newswire / April 14, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU)("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, tod
AVAI, LCTX, OCGN, VRTX, and LGVN Advance Cell-Based and Gene-Therapy Approaches to Age-Related Disease Issued on behalf of Avaí Bio, Inc. Companies mentioned
Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference
08:00am, Tuesday, 07'th Apr 2026
LAS VEGAS, April 7, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-re
Scalable Biotech Manufacturing Unlocks a $14B Market
09:15am, Friday, 27'th Mar 2026
/PRNewswire/ -- USANewsGroup.com News Commentary - The global cell therapy manufacturing market is hitting a pivotal inflection point. It's projected to
Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland
08:00am, Tuesday, 17'th Mar 2026
KELOWNA, BC / ACCESS Newswire / March 17, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of ultra-premium cannabis products, today announced
Avant Brands Continues to Strengthen Balance Sheet with $1.77 Million Debt Retirement at $0.935 Per Unit
08:00am, Monday, 09'th Mar 2026
KELOWNA, BC / ACCESS Newswire / March 9, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), is pleased to announce that it has entered into a debt settlement agreem
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
10:02am, Tuesday, 03'rd Mar 2026
/PRNewswire/ -- USANewsGroup.com News Commentary - The global cell therapy market is projected to surpass $8.2 billion in 2026, driven by a wave of clinical
Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards
08:30am, Tuesday, 03'rd Mar 2026
LAS VEGAS, March 3, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-re
Avant Brands Reports Audited Fiscal 2025 Results with 19% Recreational Revenue Growth
08:00am, Monday, 02'nd Mar 2026
Record Operating Cash Flow: Generated $5.7 million in operating cash flow, up significantly from $0.5 million in FY 2024. Recreational Revenue Growth: Increased 19% to $14.8 million, driven by blk mkt
Sign In
Buy AVAI